与非酒精性脂肪性肝病患者的晚期纤维化相关的因素
Marina Jarschel Souza1, Jessica Goedert Pereira1, Ana Carolina de Souza Mangrich1
1Gastroenterology, Department of Internal Medicine - Federal University of Santa Catarina. Brasil. Universidade Federal de Santa Catarina Gastroenterology, Department of Internal Medicine Federal University of Santa Catarina Brazil.
Acta gastroenterologica Latinoamericana
|December 4, 2025
概括
甲状腺功能低下症与非酒精性脂肪肝患者的晚期肝纤维化有关. 非侵入性标志物显示出在门诊环境中识别纤维化的前景.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 内分泌学 在内分泌学.
- 临床诊断 临床诊断 临床诊断
背景情况:
- 非酒精性脂肪性肝病 (NAFLD) 涵盖从肥胖症到肥胖肝炎的疾病,可能会进展为肝硬化和肝细胞癌.
- 肝活检是NAFLD诊断的黄金标准,但非侵入性方法对于评估肝纤维化至关重要,肝纤维化是死亡率的一个关键预测因素.
研究的目的:
- 在活检确认的NAFLD患者中确定与晚期纤维化相关的临床和实验室特征.
- 评估NAFLD中晚期纤维化非侵入性标记的诊断性能.
主要方法:
- 在门诊肝病诊所治疗的81名NAFLD患者的横截面研究 (2013-2016).
- 分析了临床数据,实验室结果和肝脏活检结果.
- 评估了非侵入性纤维化得分 (纤维化4,NAFLD纤维化得分,GGT-血小板比率,AST-ALT比率).
主要成果:
- 甲状腺功能低下与晚期纤维化独立相关 (OR=4.975,p=0.043).
- 晚期纤维化与更高的TSH,AST,GT和LDL水平相关.
- 非侵入性标志物表现中等:纤维化4 (AUC=0.723),NAFLD纤维化得分 (AUC=0.713),GT-血小板比率 (AUC=0.697),AST-ALT比率 (AUC=0.689).这些标志物表现中适度:纤维化4 (AUC=0.723),NAFLD纤维化得分 (AUC=0.713),GT-血小板比率 (AUC=0.697),AST-ALT比率 (AUC=0.689).
结论:
- 甲状腺功能低下是NAFLD中晚期肝纤维化的一个独立风险因素.
- 非侵入性标记可以帮助在门诊环境中识别晚期纤维化患者.
相关概念视频
Ultrasound II: Endoscopic Ultrasound and FibroScan
506
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
506
Chronic Pancreatitis I: Introduction
648
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
648
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
203
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
203
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
169
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
169
Diseases of the Liver and Gallbladder
1.8K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.8K
Liver Regeneration
4.2K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.2K


